× Home Screening and diagnosis of type 2 diabetesGlycaemic monitoring and targets for type 2 diabetesLifestyle managementNon-insulin medicationsInsulinScreening and management of complications of diabetesManagement of cardiovascular risk factors in diabetesManagement of hypoglycaemiaSick day managementDiabetes in pregnancyDiabetes and drivingPrediabetesGo to the NZSSD site

Type 2 Diabetes Management Guidelines

DPPIV inhibitors

  • Adverse effects of DPPIV inhibitors
  • Nausea, vomiting, anorexia and diarrhoea
  • Nasopharyngitis
  • Hepatotoxicity
  • Myalgias and muscle weakness (rare)
  • Skin reactions including Stevens-Johnson’s syndrome (rare)